A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic Migraine
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gregory Sullivan, MD
Tonix Pharmaceuticals
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Preferred Research Partners, Inc.
Little Rock, Arkansas, United States
- Synergy Research Centers - Synergy San Diego
Lemon Grove, California, United States
- Excell Research
Oceanside, California, United States
- Viking Clinical Research, Ltd
Temecula, California, United States
- Clinical Neuroscience Solutions, Inc.
Jacksonville, Florida, United States
- Segal Trials - Miami Lakes Medical Research Outpatient Site
Miami Lakes, Florida, United States
- Clinical Neuroscience Solutions, Inc.
Orlando, Florida, United States
- Diamond Headache Clinic
Chicago, Illinois, United States
- Integrated Clinical Trial Services, Inc.
West Des Moines, Iowa, United States
- Alliance for Multispecialty Research - Wichita West
Wichita, Kansas, United States
- Delricht Research - Lcmc Health Urgent Care
New Orleans, Louisiana, United States
- Delricht Research - Neighborhood Health
Prairieville, Louisiana, United States
- Boston Clinical Trials, Inc.
Boston, Massachusetts, United States
- Michigan Headache & Neurological Institute
Ann Arbor, Michigan, United States
- Delricht Research - Gulfport Memorial
Gulfport, Mississippi, United States
- Clinvest Research
Springfield, Missouri, United States
- Alliance for Multispecialty Research - Las Vegas
Las Vegas, Nevada, United States
- Upstate Clinical Research Associates, Llc
Williamsville, New York, United States
- Peters Medical Research
High Point, North Carolina, United States
- Ips Research Company, Inc.
Oklahoma City, Oklahoma, United States
- Delricht Research - Grassroots Healthcare
Tulsa, Oklahoma, United States
- Coastal Carolina Research Center
North Charleston, South Carolina, United States
- Clinical Neuroscience Solutions, Inc.
Memphis, Tennessee, United States
- Austin Clinical Trial Partners
Austin, Texas, United States
- Charlottesville Medical Research, Llc
Charlottesville, Virginia, United States
- Clinical Investigation Specialists, Inc.
Kenosha, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 6 Dec 2022
- Primary completion
- 8 Oct 2023
- Completion
- 23 Oct 2023
- Last update posted
- 25 Feb 2025
- Registered enrollment
- 88
- Registry id
- NCT05679908
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.